Haemophilias A and B
- PMID: 12781551
- DOI: 10.1016/S0140-6736(03)13405-8
Haemophilias A and B
Abstract
The haemophilias are inherited disorders in which one of the coagulation factors is deficient. Although deficiencies of factor VIII (haemophilia A) and factor IX (haemophilia B) are well recognised, von Willebrand's disease is much more common. Rare defects can occur in any of the coagulation factors. In the past, men with haemophilia were likely to die in their youth. With advances in diagnosis, and especially with development of safe and effective treatment, affected individuals can now look forward to a normal life expectancy. Complications of the disorder, particularly the development of antibodies that make treatment ineffective, and of treatment, such as transfusion-transmitted infections, have taken a severe toll on these patients. The future holds the realistic possibility of gene therapy. However, we must not forget that haemophilia is a worldwide disorder that requires significant economic resources not available for the majority.
Similar articles
-
Genetic diagnosis of haemophilia and other inherited bleeding disorders.Haemophilia. 2006 Jul;12 Suppl 3:82-9. doi: 10.1111/j.1365-2516.2006.01263.x. Haemophilia. 2006. PMID: 16684001 Review.
-
Recent advances in the detection of carriers of haemophilia A, B and Von Willebrand's disease.Haematologica. 1983 Jan-Feb;68(1):124-34. Haematologica. 1983. PMID: 6404703 No abstract available.
-
[Physiopathology and therapy of hemophilia and von Willebrand's disease].Nihon Naika Gakkai Zasshi. 1991 Jun 10;80(6):866-74. Nihon Naika Gakkai Zasshi. 1991. PMID: 1919201 Japanese. No abstract available.
-
[Intragenic polymorphisms of factor VIII and IX genes and their utility in the indirect diagnosis of carriers of Haemophilias A and B].Invest Clin. 2010 Sep;51(3):391-401. Invest Clin. 2010. PMID: 21305775 Spanish.
-
[Hemophilia].Rinsho Ketsueki. 2013 Feb;54(2):189-97. Rinsho Ketsueki. 2013. PMID: 23470826 Review. Japanese. No abstract available.
Cited by
-
Enhanced Proteolytic Processing of Recombinant Human Coagulation Factor VIII B-Domain Variants by Recombinant Furins.Mol Biotechnol. 2016 Jun;58(6):404-14. doi: 10.1007/s12033-016-9939-9. Mol Biotechnol. 2016. PMID: 27126696
-
Comparison of analgesic consumption of hemophilic and non-hemophilic patients in knee arthroplasty.Ulus Travma Acil Cerrahi Derg. 2022 Nov;28(11):1616-1621. doi: 10.14744/tjtes.2021.47482. Ulus Travma Acil Cerrahi Derg. 2022. PMID: 36282160 Free PMC article.
-
Advanced therapies for the treatment of hemophilia: future perspectives.Orphanet J Rare Dis. 2012 Dec 13;7:97. doi: 10.1186/1750-1172-7-97. Orphanet J Rare Dis. 2012. PMID: 23237078 Free PMC article. Review.
-
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments.Semin Thromb Hemost. 2023 Sep;49(6):609-620. doi: 10.1055/s-0042-1758870. Epub 2022 Dec 6. Semin Thromb Hemost. 2023. PMID: 36473488 Free PMC article.
-
Clinicopathological features of hemophilia in a tertiary care centre of India.J Family Med Prim Care. 2021 Jan;10(1):295-299. doi: 10.4103/jfmpc.jfmpc_1564_20. Epub 2021 Jan 30. J Family Med Prim Care. 2021. PMID: 34017743 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous